Diverse biology of breast cancer: search for adequate treatment

Бесплатный доступ

The article describes the results of the latest studies focused on the mechanisms of resistance for endocrine therapy of ER+ luminal tumors and anti-HER2 therapy of HER2-positive tumors. Also the author gives an information about six molecular-genetic subtypes among triple-negative breast cancer (BC) concluding that more precise molecular-genetic tests of clinical subtypes (IHC) would improve planning of adequate treatment.

Pathological subtypes of breast cancer, systematic treatment

Короткий адрес: https://sciup.org/140222659

IDR: 140222659   |   DOI: 10.18027/2224-5057-2016-3-5-10

Статья научная